Top broker rates Xero share price a buy with 20% upside

This large ASX tech share could keep rising.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • The broker Citi thinks the Xero share price has plenty of potential
  • It notes the company’s latest price increase for subscribers, which could boost average revenue per user
  • Xero itself is heavily investing in growth

The Xero Limited (ASX: XRO) share price has had a very volatile 2022 so far. In recent weeks, it has been rising and top broker Citi has a positive outlook for the company's ongoing growth.

Xero is a large cloud accounting technology business. It has built a global subscriber base, with a particularly large presence in Australia, the United Kingdom, and New Zealand.

At the time of writing, the Xero share price is down 39% in 2022. That compares to a 10% fall for the S&P/ASX 200 Index (ASX: XJO). However, since the beginning of July, Xero shares have gone up by 16%.

There has been a lot of investor attention on inflation and what this means for central bank interest rates. In theory, higher interest rates are meant to lead to lower asset values.

The ASX and other share markets are meant to be forward-looking. In other words, investors have tried to 'price in' the expected changes in the economic environment. Investors have estimated where they think interest rates will go, and therefore how various ASX shares should be valued.

Some brokers are seeing opportunities in the sell-off.

A young couple sits at their kitchen table looking at documents with a laptop open in front of them.

Image source: Getty Images

Bullish Xero share price target

Citi is one of the brokers that rates Xero a buy with a share price target of $108. Based on Tuesday's closing Xero share price of $89.18, this implies a possible rise of around 20%.

One of the main reasons for that price target is the fact that the company is increasing its prices for subscribers in the UK, Australia, and New Zealand. Not only does this imply that Xero management thinks the company's market strength is good, but it can also lead to increased revenue.

Citi thinks that the higher subscription price will lead to a rise of close to 10% for Xero's average revenue per user (ARPU), which could lead to the business doing better than previously predicted.

The broker also noted that Xero has been hiking its subscription prices at a faster rate than it used to.

Morgan Stanley is another broker that is optimistic about the Xero share price with a target of $148. But this rating is a bit older than Citi's. Morgan Stanley is also optimistic about the company's long-term future.

Xero is also focused on the long term. When the company released its FY22 results, Xero CEO Steve Vamos said:

We are committed to delivering the world's most insightful and trusted small business platform by focusing on driving cloud accounting adoption, growing the small business platform and building for global scale and innovation.

We continue to prioritise investment in building products and growing partnerships by investing cash generated to help deliver our strategy, drive long-term growth and meet customer needs.

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Xero. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Technology Shares

Happy investor on tablet with finance graphs rising in overlay.
Technology Shares

WiseTech shares are taking off: Is this the start of a major comeback?

Strong FY26 results could trigger a major WiseTech valuation rethink.

Read more »

A couple sit in front of a laptop reading ASX shares news articles and learning about ASX 200 bargain buys
Earnings Results

FINEOS swings to profit in 1H26

FINEOS posted higher revenue, swung to profit, and outlined growth plans.

Read more »

Two IT professionals walk along a wall of mainframes in a data centre discussing various things
Technology Shares

Megaport shares are up more than 100% in 3 months. Are they still a buy?

Can the AI hype drive this stock even higher?

Read more »

A graphic showing a businessman running up a white upwards rising arrow symbolising the soaring Magellan share price today
Broker Notes

Up 250%! Broker tips this dividend paying ASX All Ords tech stock for more outsized gains

A top broker forecasts more outperformance from this dividend paying ASX tech stock.

Read more »

A man in his 30s holds his laptop and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
Technology Shares

Bravura Solutions FY26 earnings: Revenue, profit, and dividends climb

Bravura Solutions surged 13% yesterday after releasing the result.

Read more »

A line up of job interview candidates sit in chairs against a wall clutching CVs on paper in an office setting.
Technology Shares

Seek shares plunge 14% despite solid results: Did investors overreact?

The market may be pricing in slower growth, weaker guidance and long-term AI disruption.

Read more »

Man analysing data on his laptop.
Technology Shares

Why this could be the best ASX tech stock to buy and hold

Xero already has almost five million customers, but I think there is still plenty of room for the business to…

Read more »

Businesswoman with a pleased smile reading on her laptop at a desk in the office with a look of satisfaction.
Technology Shares

Pro Medicus lands $23m St. Luke's Health System imaging contract

St. Luke’s Health System is Idaho’s largest private employer and not-for-profit healthcare provider.

Read more »